Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 5/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | RXRG | P48443 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.36 |
| ▸ | GLRB | P48167 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2163934 | 0.84 | POLB (0.42) | NPSR1POLBNR1H4FFAR4RXRA | |
| SCHEMBL11581053 | 0.81 | NPSR1 (0.49) | NPSR1POLBNR1H4RXRARXRB | |
| SCHEMBL8520513 | 0.81 | POLB (0.42) | NPSR1POLBNR1H4FFAR4RXRA | |
| SCHEMBL23940954 | 0.79 | CA2 (0.45) | NPSR1POLBCA2GABRA1GABRB2 | |
| SCHEMBL30501159 | 0.79 | CA2 (0.52) | NPSR1POLBNR1H4CA2GABRA1 | |
| SCHEMBL4975584 | 0.79 | CA2 (0.52) | NPSR1POLBNR1H4CA2GABRA1 | |
| SCHEMBL740968 | 0.79 | POLB (0.50) | NPSR1POLBNR1H4RXRARXRB | |
| SCHEMBL16196207 | 0.78 | NPSR1 (0.46) | NPSR1POLBNR1H4RXRARXRB | |
| SCHEMBL7693390 | 0.77 | NR1H4 (0.48) | NPSR1POLBNR1H4FFAR4RXRA | |
| Methane SCHEMBL8628685 | 0.77 | POLB (0.49) | NPSR1POLBNR1H4RXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4333852-A1 | LARGE-CONDUCTANCE POTASSIUM CHANNEL MODULATORS, COMPOSITIONS THEREOF, METHODS OF MANUFACTURING THEREOF, AND METHODS OF USE THEREOF | Enalare Therapeutics Inc. (US) | 2024-03-13 | — | — | EP | disclosed |
| EP-4333807-A1 | NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) COMPOSITIONS, METHODS OF MANUFACTURING THEREOF, AND METHODS OF USE THEREOF | Sovida Solutions Ltd. (GB) | 2024-03-13 | — | — | EP | disclosed |
| EP-4312941-A1 | PHOSPHOLIPIDS AS ANION CHELATING AGENTS IN PHARMACEUTICAL FORMULATIONS | R.P. Scherer Technologies, LLC (US) | 2024-02-07 | — | — | EP | disclosed |
| EP-4121164-A1 | MEDICATED CANNABINOID COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT | Tauriga Sciences Inc. (US) | 2023-01-25 | — | — | EP | disclosed |
| WO-2022197581-A1 | NON-ORAL MEDICATED CANNABINOID COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT | TAURIGA SCIENCES INC. (US) | 2022-09-22 | — | — | WO | disclosed |
| WO-2021188612-A1 | MEDICATED CANNABINOID COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT | TAURIGA SCIENCES INC. (US) | 2021-09-23 | — | — | WO | disclosed |
| EP-3850040-A1 | A STABILIZED CHLORINATED POLYVINYLCHLORIDE AND AN ARTICLE MADE THEREFROM | Reagens S.p.A. (IT) | 2021-07-21 | — | — | EP | disclosed |
| WO-2021087210-A1 | SUPPOSITORY CAPSULE | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2021-05-06 | — | — | WO | disclosed |
| EP-3649189-A1 | A POLYETHYLENE PIPE | BASF SE (DE) | 2020-05-13 | — | — | EP | disclosed |
| WO-2020053157-A1 | A STABILIZED CHLORINATED POLYVINYLCHLORIDE AND AN ARTICLE MADE THEREFROM | REAGENS S.P.A. (IT) | 2020-03-19 | — | — | WO | disclosed |
| WO-2012004377-A1 | STABILIZING COMPOSITION FOR HALOGEN-CONTAINING POLYMERS | REAGENS S.P.A. (IT) | 2012-01-12 | — | — | WO | disclosed |
| WO-2012000992-A1 | PROCESS FOR IMPROVING THE FLOW PROPERTIES OF POLYMER MELTS | BASF SE (DE) | 2012-01-05 | — | — | WO | disclosed |
| EP-2150576-A1 | STABILIZATION OF POLYMERS WITH STYRENATED-P-CRESOLS | CHEMTURA CORPORATION (US) | 2010-02-10 | — | — | EP | disclosed |
| WO-2008144086-A1 | STABILIZATION OF POLYMERS WITH STYRENATED-P-CRESOLS | CHEMTURA CORPORATION (US) | 2008-11-27 | — | — | WO | disclosed |
| US-6770693-B2 | COMPRISING BIS-(2,4-DICUMYLPHENYL) PENTAERYTHRITOL DIPHOSPHITE AND HINDERED PHENOL ANTIOXIDANTS USEFUL AS STABILIZERS AGAINST THERMOOXIDATIVE DEGRADATION OF POLYMERS DURING MELT PROCESSING | DOVE CHEMICAL CORPORATION | 2004-08-03 | — | — | US | disclosed |
| US-20030225192-A1 | Mxitures of 2-(2-hydroxy-4(3-butoxy-2-hydroxypropyloxy)-phenyl )-4,6-bis(2,4-dimethylphenyl)-1,3,5-triazine and hindered amine light stabilizers, used for stabilization of curable polycarbonates | BIRBAUM JEAN-LUC (CH) | 2003-12-04 | — | — | US | disclosed |
| US-20020040081-A1 | Blends of phosphites and antioxidants | DOVER CHEMICAL | 2002-04-04 | — | — | US | disclosed |
| US-6359148-B1 | FOR POLYMER, LUBRICANTS; HEAT, OXIDATION RESISTANCE, PHOTOSTABILITY | NESVADBA PETER (CH) | 2002-03-19 | — | — | US | disclosed |
| EP-1087947-A2 | TRISARYL-1,3,5-TRIAZINE ULTRAVIOLET LIGHT ABSORBERS CONTAINING HINDERED PHENOLS | Ciba SC Holding AG (CH) | 2001-04-04 | — | — | EP | disclosed |
| WO-1999067223-A2 | TRISARYL-1,3,5-TRIAZINE ULTRAVIOLET LIGHT ABSORBERS CONTAINING HINDERED PHENOLS | CYTEC TECH CORP (US) | 1999-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225192-A1 | Mxitures of 2-(2-hydroxy-4(3-butoxy-2-hydroxypropyloxy)-phenyl )-4,6-bis(2,4-dimethylphenyl)-1,3,5-triazine and hindered amine light stabilizers, used for stabilization of curable polycarbonates | SIGMAR1, H1-2, H1-5 | NPSR1 520/4885POLB 653/4885NR1H4 3074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.